Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors.

Jensen Yeung Ron Vender Irina Turchin Rahul Shukla Catherine Maari Chih-Ho Hong Maxime Barakat Perla Lansang

J Am Acad Dermatol

Department of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada.

Published: April 2021

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2020.11.013	DOI Listing

Publication Analysis

Top Keywords

brodalumab success

success patients

patients moderate-to-severe

moderate-to-severe psoriasis

psoriasis failed

failed previous

previous interleukin-17a

interleukin-17a inhibitors

brodalumab

patients

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!